Home » Topics » BioWorld Science

BioWorld Science
RSS

Bat3 as potential therapeutic target and endogenous regulator of DC function

March 24, 2022

Roche discloses new MAGL inhibitors

March 24, 2022

Kezar Life Sciences presents new protein secretion inhibitors

March 24, 2022

Korean researchers identify new NADPH oxidase inhibitors

March 24, 2022

Massachusetts Institute of Technology divulges new c-Myb inhibitors

March 24, 2022

Emory University patents thymidylate synthase inhibitors

March 24, 2022

Genentech degrader-antibody conjugates targeting BRD4 show anticancer activity

March 24, 2022

A novel series of pyrralothiazole-based dual TLR7/8 antagonists for the potential treatment of lupus

March 24, 2022

MR-2088: a first-reported ULK1 inhibitor for RAS-driven cancers

March 24, 2022

GS-621763, oral prodrug with efficacy in models of SARS-CoV-2 infection

March 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...